Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-14-000807
Filing Date
2014-02-12
Accepted
2014-02-12 16:22:10
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO REGISTRATION STATEMENT fs12014a1_actinium.htm S-1/A 2910591
2 OPINION OF HISCOCK & BARCLAY, LLP fs12014a1ex5i_actinium.htm EX-5.1 8365
3 CONSENT OF GBH CPAS, PC fs12014a1ex23i_actinium.htm EX-23.1 2978
4 logo.jpg GRAPHIC 7982
  Complete submission text file 0001213900-14-000807.txt   11666414

Data Files

Seq Description Document Type Size
5 fil-20130930.xml EX-101.INS 1657439
6 fil-20130930.xsd EX-101.SCH 88179
7 fil-20130930_cal.xml EX-101.CAL 46616
8 fil-20130930_def.xml EX-101.DEF 303662
9 fil-20130930_lab.xml EX-101.LAB 619077
10 fil-20130930_pre.xml EX-101.PRE 437791
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-193714 | Film No.: 14600536
SIC: 6770 Blank Checks